Last reviewed · How we verify

NCT04113369

Upper Limb Cross-education in Subacute Stroke

Completed NA Last updated 10 April 2020
What this trial tests

NA trial testing TENS in Hemiplegia in 30 participants. Completed in 30 July 2019.

Timeline
30 May 2018
Primary endpoint
30 July 2019
30 July 2019

Quick facts

Lead sponsorBezmialem Vakif University
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingnone
Primary purposescreening
Enrollment30
Start date30 May 2018
Primary completion30 July 2019
Estimated completion30 July 2019
Sites1 location across Turkey (Türkiye)

Drugs / interventions tested

Conditions studied

Sponsor

Bezmialem Vakif University

Who can join

18 and older, any sex, with Hemiplegia or Stroke. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study evaluates how cross-education (unilateral training) affects muscle strength of the paretic limb in acute stroke patients. Half of the hemiplegic patients will receive conventional treatment and transcutaneous electrical nerve stimulation (TENS) to non-paretic side, while other half will receive conventional treatment and electro muscular stimulation (EMS) to non-paretic side.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. How does cross-education affects muscles of paretic upper extremity in subacute stroke survivors?
    Yurdakul OV, Kilicoglu MS, Rezvani A, Kucukakkas O, et al · · 2020 · cited 5× · PMID 32506358 · DOI 10.1007/s10072-020-04506-2

Verify or expand the search:

Other trials of TENS

Trials testing the same drug.

Other recruiting trials for Hemiplegia

Currently open trials in the same condition.

Other Bezmialem Vakif University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04113369.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing